EIF2AK3 and diabetes mellitus: For example, heterozygous deletion of Eif2ak3 in Akita mutant mice (which develop β cell loss and diabetes owing to a mutation in proinsulin that cripples its folding) significantly delays diabetes onset, a phenotype replicated by use of low-dose PERK inhibitors in these mice (17).